The present study was designed to evaluate the effect of olive oil and its main polyphenol (oleuropein) in ovariectomised rats with or without inflammation. Rats (6 months old) were ovariectomised or sham-operated as control. Ovariectomised rats were separated into three groups receiving different diets for 3 months: a control diet with 25 g peanut oil and 25 g rapeseed oil/kg (OVX), the control diet with 50 g olive oil/kg or the control diet with 0·15 g oleuropein/kg. The sham-operated group was given the same control diet as OVX. Inflammation was induced 3 weeks before the end of the experiment by subcutaneous injections of talc (magnesium silicate) in one-half of each group. The sucess of ovariectomy was verified at necropsy by the atrophy of uterine horns. Inflammation, oleuropein or olive oil intakes did not have any uterotrophic activity, as they had had no effect on uterus weight. The plasma concentration of a-1-acid glycoprotein (an indicator of inflammation) was increased in OVX rats with inflammation. With regard to bone variables, osteopenia in OVX was exacerbated by inflammation, as shown by a decrease in metaphyseal and total femoral mineral density. Both oleuropein and olive oil prevented this bone loss in OVX rats with inflammation. At necropsy, oleuropein and olive oil consumption had had no effect on plasma osteocalcin concentrations (marker of bone formation) or on urinary deoxypyridinoline excretion (marker of bone resorption). In conclusion, oleuropein and olive-oil feeding can prevent inflammation-induced osteopenia in OVX rats.
With the continuing demographic shift in population toward an older society, all industrialised countries face a growing prevalence of chronic age-related conditions. Development of degenerative diseases such as osteoporosis, characterised by a low bone-mass and microarchitectural deterioration (Consensus Development Statement, 1997 ) and a steep age-related incidence, has a major impact on the health of elderly populations in the western world. Hip fractures are associated with considerable morbidity and even lead to an overall mortality of 15 -30 % (Browner et al. 1996) . Vertebral fractures also lead to reduced survival, probably due to clustering of co-morbidity (Cooper et al. 1993) .
It has been suggested that the decline in sex hormones at the time of menopause heightens the risk of osteoporosis (Ershler et al. 1997) . In fact, ageing and oestrogen deficiency induce inflammatory and oxidant conditions that are involved in the development of this chronic disease (Das, 2002) . Indeed, plasma concentrations of proinflammatory cytokines (IL-1, IL-6 and TNF-a of macrophagic or monocytic origin) increase in postmenopausal women (Zeng et al. 1997 ). Furthermore, the in vitro production of cytokines by peripheral blood monocytes is greater in postmenopausal women (Cohen-Solal et al. 1993 ). In addition, Pacifi et al. (1991) found that in women oophorectomy-induced menopause caused an increase in cytokine production involved in bone resorption. This effect was prevented by oestrogen-replacement therapy. A high cytokine secretion may give rise to osteoclastic differentiation through the prostaglandin pathway (Horowitz & Raisz, 1999) . Moreover, those cytokines are also involved in the release of free radicals (Das, 1991) , which, in turn, may have a role in the development of osteoporosis by inhibiting osteoblastic recruitment and the activity of mature cells (Mody et al. 2001) , and by increasing osteoclastic resorption (Watkins et al. 2001) .
Research in nutrition in the past 30 years has lent support to the hypothesis that by modulating specific target functions in the body, diet can help to achieve optimal health by reducing the risk of disease (Diplock et al. 1999) . Specifically, it has been recognised that the human diet contains, in addition to essential macronutrients, a complex array of naturally occurring bioactive molecules, including the phytochemicals endowed with antioxidant and antiinflammatory properties. Antioxidant nutrients may enhance bone formation and reduce the production of free radicals that contribute to bone resorption (Keys et al. 1986 ). Thus, there is an increasing rationale for focus on the Mediterranean diet, known for its antioxidant nutrients (within Europe the lowest incidence of osteoporosis has been reported in the Mediterranean area (Kanis, 1993; European Commission, 1998 ; Table 1) ). This diet is mainly characterised by its high content of olive oil, which contains a series of phenolic minor compounds such as hydroxytyrosol and oleuropein, known to scavenge superoxide radicals and inhibit neutrophils respiratory burst (Visioli et al. 1998) .
Consequently, we have examined the consumption of olive oil and its main polyphenol (oleuropein) as a possible way of preventing bone loss in the ovariectomised rat with or without chronic inflammation.
Materials and methods

Animals and treatments
The present study was conducted in accordance with current legislation on animal experiments in France. Female Wistar rats (n 80, 6 months old) were purchased from a laboratory colony (National Institute for Agricultural Research (INRA), Clermont-Ferrand/Theix, France) and housed individually at 218C with a 12 h light -dark cycle. They were sham-operated (n 20) or surgically ovariectomised (n 60) under anaesthesia using chloral hydrate (Fluka Chemie AG, Buchs, Switzerland; 80 g/l saline solution (9 g NaCl/l); 4 ml/kg body weight, intraperitoneally). After an adaptation period of 7 d with a semipurified standard diet (Table 2; INRA, Jouy en Josas, France) mixed with 25 g peanut oil (Lesieur Alimentaire, Asnieres sur Seine, France) and 25 g rapeseed oil (Auchan Alimentaire, Lyon, France)/kg, the rats were randomly assigned to four groups: (1) untreated (SH: sham-operated controls receiving the control diet); (2) untreated (OVX: ovariectomised controls also given the control diet); (3) ovariectomised rats given the control diet supplemented with 0·15 g oleuropein/kg (OL); (4) ovariectomised rats animals given the semipurified diet mixed with 50 g extra virgin olive oil (Puget, Rueil Malmaison, France)/kg (HO). Oils were stored sheltered from the light. Diets were prepared every week and stored at 48C. During the 80 d experimental period, the quantity of diet given to each rat per d was adjusted to the mean level consumed by SH animals the previous day, in order to prevent ovariectomy-induced hyperphagia. Three weeks before the end of the experiment (day 59), inflammation was induced in ten animals of each group by four separate subcutaneous injections of talc (magnesium silicate; 3·2 g per animal) in sterile saline (9 g NaCl/l). On days 41 and 80, blood samples were taken and the 24 h urine samples collected (started at 09.00 hours) to measure urinary excretion of deoxypyridinoline (DPD), a marker of bone resorption, and osteocalcin, a marker of bone formation. At necropsy (day 80) blood samples were collected to assess osteocalcin, a-1acid glycoprotein and the ferric-reducing ability of plasma. The spleen, heart and uterine horns were removed and weighed. The hearts were washed in ice-cold saline (9 g/l NaCl), placed in liquid N 2 and stored at 2 808C until the susceptibility to peroxidation was carried out. Left and right femurs were cleaned from adjacent tissues and collected for mechanical testing and bone mineral density (BMD) measurements respectively.
Oleuropein preparation
Leaves of Olea europea var. koroneiki were collected in Crete, dried at room temperature and pulverised. The powdered leaves (7 kg) were then completely extracted with dichloromethane, methanol and water. The methanol extract was evaporated to dryness and a 130 g sample was subjected to chromatographic fractionation with a CH 2 Cl 2 -MeOH solvent system of increasing polarity, to give twenty fractions. Fractions 8 -9 were eluted with CH 2 Cl 2 -MeOH (90:10, v/v) and yielded 50 g oleuropein. The purity of oleuropein was determined by HPLC and NMR spectral analysis as described by Tsarbopoulos et al. (2003) .
Bone mineral density
BMD was assessed by dual-energy X-ray absorptiometry with a Hologic QDR-4500 A X-ray bone densitometer (Hologic, Massy, France). The total right femur BMD, as well as the BMD of two sub-regions, one corresponding to the distal femur metaphyseal zone, rich in cancellous bone, and the other to the diaphyseal area, rich in cortical bone, were determined. The intra-and inter-assay CV for femoral assays were 0·22 and 0·24 % respectively. 
Femoral mechanical testing
After collection of the left femurs in NaCl (9 g/l), the length and the mean diameter of the diaphysis were measured with a precision caliper (Mitutoyo, Telford, Shropshire, UK). Femoral failure load was then determined, using a threepoint bending test (Turner & Burr, 1993) , with a Universal Testing Machine (Instron 4501, Instron, Canton, MA, USA). Each bone was secured on the two lower supports (diameter 4 mm, length 20 mm) on the anvil of the testing machine. The upper roller diameter was 6 mm and the crosshead speed was 0·5 mm/min. The span of the specimen that was loaded was 20 mm to ensure that 85 -90 % of the bone flexure was caused by bending.
Marker of bone formation
Osteocalcin in plasma was measured by RIA using rat 125 Ilabelled osteocalcin, goat anti-rat osteocalcin antibody and donkey anti-goat second antibody (Biochemical Technologies, Stoughton, MA, USA). The sensitivity was 0·01 nmol/l. The intra-and inter-assay CV were 6·8 and 8·9 % respectively.
Marker of bone resorption
Free DPD in urine was determined by competitive RIA, using rat monoclonal anti-DPD antibody coated to the inner surface of a polystyrene tube and 125 I-labelled DPD (Pyrilinks-D RIA kit; Metra Biosystems, Mountain View, CA, USA). The sensitivity was 2 nmol/l. The intra-and inter-assay CV were 4 and 6 % respectively. Results were expressed as nmol DPD/mmol creatinine (Robbins, 1994) . The creatinine assay (Kit Bio MERIEUX SA, Marcy-l'Etoile, France) is based on a modified Jaffe's method, in which picric acid forms a coloured solution in the presence of creatinine (Cook, 1975) .
Marker of inflammation
Plasma a-1-acid glycoprotein, an acute-phase protein, was determined by single radial immunodiffusion using rabbit anti-rat a-1-acid glycoprotein antibodies (Breuillé et al. 1998) . The minimum detection level was 4 mg/ml and the precision 1·5 mg/ml.
Markers of oxidative stress
The susceptibility of the heart to peroxidation was determined in tissue homogenates by measuring the thiobarbituric acid-reactive substances after a lipid peroxidation was induced with 2 mM-FeSO 4 -50 mM-ascorbate (Sigma, St Quentin Fallavier, France) for 30 min in a water-bath at 378C, using a standard of 1,1,3,3-tetraethoxypropane as previously described (Ohkawa et al. 1979) . The CV were 4·32 and 2·10 % for the basic and stimulated methods respectively. Ferric-reducing potential was determined using the method of Benzie & Strain (1996) ; this method evaluates the reduction of ferric iron to the ferrous form in the presence of antioxidant components. The colorimetric measurement was performed at 593 nm and the reaction was monitored for up to 8 min on 25 ml samples. Results were calculated from a standard scale of FeSO 4 . Withinand between-run CV were , 1·0 and , 3·0 % respectively at 100-1000 mmol/l.
Statistical methods
Results are expressed as mean values with their standard errors. A parametric one-way ANOVA was performed to test for any difference among groups. If the result was found to be significant (P, 0·05), the Student -Newman -Keuls multiple comparison test was then used to determine specific differences between mean values. If a parametric ANOVA was not feasible (when there were significant differences between the SD groups by Kolmogorov -Smirnov test), a Kruskall -Wallis test followed by the Mann -Whitney Wilcoxon U-test was carried out to compare differences between groups.
Results
Body and uterine weight
In each group the body weight increased between day 0 and 80. However, although consuming similar amounts of food, because of pair-feeding, body weight was greater in OVX than in SH by the fourth week of the experiment and this trend was still evident on day 80 (OVX 294 (SEM 6), SH 275 (SEM 6) g; P, 0·001). Oleuropein or olive-oil consumption did not prevent this weight gain after ovariectomy. Inflammation induced a decrease in body weight in OVX (OVX with inflammation 333 (SEM 9), OVX without inflammation 355 (SEM 9) g; P, 0·05) ( Fig. 1) .
The success of ovariectomy was confirmed by uterine atrophy in OVX rats (OVX 0·32 (SEM 0·03), SH 2·21 (SEM 0·17) g uterus/kg body weight; P, 0·0001). Neither inflammation (SH with inflammation 2·06 (SEM 0·43), OVX with inflammation 0·60 (SEM 0·03) g uterus/kg body weight), nor oleuropein nor olive oil intake had any further significant effect on this variable (OL 0·44 (SEM 0·04), HO 0·37 (SEM 0·02) g uterus/kg body weight; Fig. 2 ). 
Bone mineral density
No significant differences were reported in bone area between groups. BMD reflects bone mineral content:bone area ratio (Table 3) . Ovariectomy induced a significant decrease in total BMD (OVX 0·2243 (SEM 0·0031), SH 0·2378 (SEM 0·0050) g/cm 2 ; P, 0·001). Inflammation exacerbated this osteopenia, but was devoid of any effect in SH rats (OVX with inflammation 0·2109 (SEM 0·0018) g/cm 2 , P, 0·01; SH with inflammation 0·236 (SEM 0·0043) g/cm 2 , NS). Oleuropein and olive oil reduced this bone loss in OVX rats with inflammation (HO with inflammation 0·2249 (SEM 0·0038), OL with inflammation 0·2258 (SEM 0·0028) g/cm 2 ). However, they had no effect in those without inflammation (HO 0·2240 (SEM 0·0048), OL 0·2170 (SEM 0·0036) g/cm 2 , NS compared with the values in OVX control rats). The same pattern was observed for metaphyseal BMD, whereas for diaphyseal BMD only olive oil and oleuropein consumption were able to elicit significant changes compared with the values measured in OVX rats with inflammation ( Fig. 3) (Table 3) .
Bone turnover
An age-related decrease in bone formation was demonstrated by a decrease in plasma osteocalcin levels throughout the experimental period. At day 41, ovariectomy elicited an increased bone turnover: plasma osteocalcin concentrations osteocalcinaemia, (ng/ml) and urine DPD excretion were greater than in control rats (OVX 33·1 (SEM 1·7), SH 21·1 (SEM 2·2) ng/ml; OVX 165·0 (SEM 9·5), SH 86·1 (SEM 7·4) nmol DPD/mmol creatinine respectively). Bone resorption was still high at the end of the experiment (day 80: OVX 175·4 (SEM 23·0), SH 91·5 (SEM 10·2) mmol DPD/mmol creatinine), whilst osteoblastic activity was not different anymore with intact (SH) animals (OVX 16·7 (SEM 2·3), SH 15·8 (SEM 0·8) ng/ml). As far as inflammation is concerned, a greater degree of osteocalcinaemia was observed in OVX with inflammation than Table 2 and pp. 120-121. Values are means with their standard errors shown by vertical bars (ten rats per group). Mean values were significantly different from those of the corresponding SH group: *P,0·05. Mean values were significantly different from those of OVX without inflammation: † †P,0·001. Mean values were significantly different from those of OVX with inflammation: ‡P,0·05. Table 2 and pp. 120-121. Values are means with their standard errors shown by vertical bars (ten rats per group). Mean values were significantly different from those of the SH at the same time point: ***P,0·001. Mean values were significantly different from those of OVX: †P,0·05. Table 2 and pp. 120-121. Values are means with their standard errors shown by vertical bars (ten rats per group). Mean values were significantly different from those of the corresponding SH group: ***P,0·001.
OVX. Finally, only the oleuropein-containing diet was able to partially improve bone resorption in OVX rats (Fig. 4) .
Femoral mechanical testing
Femoral failure load was similar in OVX with inflammation (100 (SEM 3) N) and SH with inflammation (101 (SEM 4) N). However, it was significantly greater in OL with inflammation and HO with inflammation (P, 0·05) than in OVX with inflammation ( Fig. 5 ).
Marker of inflammation
Plasma a-1-acid glycoprotein concentration was similar in all groups. This marker was increased after inflammation in oestrogen-deficient animals, but was unchanged in intact rats (OVX 22·6 (SEM 4·3), OVX with inflammation 35·9 (SEM 7·5) mg/ml, P, 0·05; SH 17·78 (SEM 2·35), SH with inflammation 18 (SEM 3·03) mg/ml). This pattern was prevented by olive oil (HO with inflammation 22·8 (SEM 1·7) mg/ml; P, 0·005) (Fig. 6 ).
The spleen weight increased after inflammation in OVX rats, while SH animals were protected (OVX 1·86 (SEM 0·08), OVX with inflammation 2·54 (SEM 0·09) g spleen/ kg body weight, P, 0·001; SH 2·18 (SEM 0·18), SH with inflammation 2·31 (SEM 0·16) g spleen/kg body weight). Both diets prevented this effect (HO with inflammation 2·15 (SEM 0·09), OL with inflammation 2·01 (SEM 0·11) g spleen/kg body weight; P, 0·05) ( Table 4) .
Markers of oxidative stress
The ferric-reducing potential value, which reflects the antioxidant capacity of plasma, was not different between groups. Thiobarbituric acid-reactive substances in the heart were also not modified by any of the diets or treatments (results not shown).
Discussion
Broad-based preventive strategies designed to lower the risks of osteoporosis need to be established and implemented. This is why the concept of a healthy diet providing adequate amounts of various potent micronutrients deserves attention. A recent interest in phenolic compounds in foods has increased greatly because of the compounds' anti-inflammatory and free radical-scavenging abilities (Bors et al. 1990; Horcajada-Molteni & Coxam, Fig. 4 . Plasma osteocalcin concentrations (A) and urinary deoxypyridinoline (B) in sham-operated (SH), ovariectomised (OVX), ovariectomised þ oleuropein (OL) and ovariectomised þ olive oil (HO) rats, with (A) or without (o) inflammation before (day 41) and after (day 80) inflammation injection. For details of diets and procedures, see Table 2 and pp. 120-121. Values are means with their standard errors shown by vertical bars (ten rats per group). Mean values were significantly different from those of SH at day 80: ***P,0·005. Mean values were significantly different from those of SH at day 41: † † †P,0·001. Mean values were significantly different from those of OVX at day 80: ‡P,0·04. Mean values were significantly different from those of OVX at day 41: §P,0·05.
2001
). We thus assessed the effect of olive oil and its major polyphenol, oleuropein, on bone loss in ovariectomised rats with chronic inflammation: gonadal failure at the time of menopause causes osteopenia in women, and with ageing, inflammatory and oxidant conditions drastically worsen as the body becomes unable to eliminate free radicals and prevent inflammation (Das, 2002) .
In the present experiment, the animals were given a control diet in which fat was replaced by olive oil (50 g/kg diet). This amount is equivalent to 61 ml/d for a 70 kg man. According to Quaranta & Rotundo (2000) , the average daily consumption of olive oil is about 55 ml in Mediterranean countries; consequently, the dose given was in the order of magnitude of the current nutritional doses in human subjects. The amount of oleuropein in the oleuropein-supplemented diet was about twice the level in the diet containing 50 g olive oil/kg.
The case of ovariectomised rats with inflammation
With regard to bone variables, a significant decrease in femoral BMD was elicited by ovariectomy, as previously shown by Miller et al. (1991) . As in human subjects (Uebelhart et al. 1991) , this bone loss probably resulted from a faster bone turnover, as indicated by higher plasma osteocalcin concentrations associated with boneformation rate (Riggs & Melton, 1986 ) and increased urinary DPD excretion associated with bone resorption (Eastell et al. 1992) in OVX rats than in SH (Fig. 4) . However, in our experimental conditions, mechanical properties (assessed by the femoral failure load), which depend on bone architecture quality, remained unchanged. This discrepancy could be explained by the fact that this variable reflects only the diaphyseal bone quality, which reacts more slowly than cancellous bone. Indeed, the lack of change in diaphyseal BMD confirms a lesser susceptibility of this tissue, as previously reported by Kalu (1991) .
A further bone loss was elicited by inflammation in the OVX rats; this loss reached 6 % of the total BMD. This alteration of trabecular bone mass was, however, quite small compared with a 64 % decrease of BMD in 1·5month-old rats (Minne et al. 1984; Vukicevic et al. 1994) . In young growing animals a decrease in osteoblastic activity and reduced growth could explain a greater effect than in our present adult animals. In trying to explain the pathogenesis of this osteopenia, Vukicevic et al. (1994) have shown that modulation of TNF-a is involved. Moreover, an increased production of NO and an activation of Table 2 and pp. 120-121. Values are means with their standard errors shown by vertical bars (ten rats per group). Mean values were significantly different from those of OVX with inflammation: *P,0·05. Table 2 and pp. 120-121. Values are means with their standard errors shown by vertical bars (ten rats per group). Mean value was significantly different from that of OVX without inflammation: ‡P,0·05. Mean value was significantly different from that of OVX with inflammation: *P,0·05. SH  0·4468  0·0173  1·8764  0·0438  0·2378  0·0050  SH inf  0·4392  0·0160  1·8541  0·0401  0·2366  0·0043  OVX  0·4261  0·0101  1·8988  0·0246  0·2243  0·0031  OVX inf  0·4020  0·0094  1·9050  0·0383  0·2109  0·0018  OL  0·4111  0·0110  1·8932  0·0281  0·2170  0·0036  OL inf  0·4217  0·0118  1·8684  0·0486  0·2258  0·0028  HO  0·4342  0·0202  1·9026  0·0470  0·2240  0·0048  HO inf  0·4391  0·0142  1·9505  0·0440 0·2249 0·0038 * For details of diets and procedures, see Table 2 and pp. 120-121.
the inducible NO synthetase in the bone marrow space have also been demonstrated (Armour et al. 1999 ). In the same way, in the present study the talc-induced-inflammation also led to an increase in inflammatory variables, such as a splenomegaly and an increase in plasma a-1acid glycoprotein. Spleen hypertrophy could be considered as a sign of activation of the immune system; the spleen plays a major role in the immune system by synthesising antibody-producing lymphocytes and filtering damaged cells of blood. Conversely, in our present study, there was no modification of thiobarbituric acid-reactive substances (peroxidation marker) or in the ferric-reducing potential (antioxidative capacity of plasma), as measured at the end of the experiment. It is thus possible that a steady-state was reached, but more probably, oil in the diet might have contained enough a-tocopherol to avoid any further free radical production after ovariectomy or inflammation. Indeed, the standard dietary fat mixture (peanut oil -rapeseed oil (50:50, w/w)) and olive oil supplied 1540 and 1380 mg a-tocopherol/kg body weight per d respectively. Vitamin E is usually an excellent inhibitor of lipid peroxidation (Chaudiere, 1994) , possibly explaining the similarity between groups. Oleuropein or olive oil prevented (at least partially) overweight in ovariectomised rats and the loss of weight after inflammation. 17b-Oestradiol has been shown to restore body weight in ovariectomised rats (Coxam et al. 1996) . Oleuropein is a polyphenol belonging to the secoiridoid class, which includes lignans, and has a stereochemistry analogous to recognised phyto-oestrogens; thus, this polyphenol could act as a phyto-oestrogen. However, the oestrogenic potency of oleuropein has not been investigated.
With regard to bone health, a protective effect of both diets was observed in inflammatory conditions. Indeed, femoral failure load and diaphyseal BMD were increased with oleuropein and olive oil in OVX with inflammation. In the same way, BMD was also improved at the trabecular level. Our present results are quite similar to those previously reported in a model for breast cancer: rats fed on a polyphenol-supplemented virgin olive oil-containing diet with inflammation induced by carrageenan (Martin-Moreno et al. 1994) . It is well known that oleuropein elicits anti-inflammatory effects by inhibiting the lipoxygenase activity and the production of leucotriene B 4 (De la Puerta et al. 1999) . Olive oil is rich in phenolic compounds, particularly oleuropein, hydroxytyrosol and tyrosol, which possess anti-inflammatory effects (De la Puerta et al. 1999) . Moreover, it is well established that the anti-inflammatory effect of olive oil depends on the polyphenol content (Martinez-Dominguez et al. 2001) and that a synergistic effect between phenolic compounds is possible. Visioli et al. (1998) has shown that extra virgin olive oil gives better protection against LDL oxidation in vitro than oleuropein or hydroxytyrosol. Even if olive oil polyphenols are absorbed in rats (Tuck et al. 2001) , as in human subjects (Vissers et al. 2002) , in our experimental conditions they did not increase the antioxidant capacity of plasma, again probably because protection was already at a maximum value.
The case of ovariectomised rats
Osteopenia due to ovariectomy was unchanged by any diet, as shown by values of BMD and markers of remodelling that changed, although on day 80 urinary DPD excretion decreased in OL rats while osteocalcinemia remained constant. This lack of effect of both olive oil and oleuropein consumption in OVX rats (an experimental model for postmenopausal osteoporosis) compared with an improvement in bone health when an inflammation was induced experimentally (a model for senile osteoporosis) could be explained by an indirect action on bone metabolism through an improvement of the inflammatory status. It is possible that inflammation elicited by OVX was not great enough (only a trend towards higher a-1-acid glycoprotein levels was demonstrated). It is well known that only molecules with oestrogenic activity are effective in the prevention of bone loss associated with early menopause. It is possible that the intrinsic oestrogenic activity of those polyphenols was not enough to directly target bone cells.
The case of sham-operated animals
The reduced susceptibility of sham-operated animals to inflammation was probably due to the protective effect of steroid hormones. Indeed, oestrogens inhibit pro-inflammatory cytokine production (IL-1, TNF-a) involved in orosomucoide synthesis (Fournier et al. 2000) . However, this protective action does not exclude other pathways such as, for example, control of immune cells recruitment and activation: Cuzzocrea et al. (2000) have shown, in an ovariectomised rat model with carrageenan-induced pleurisy, an attenuated inflammatory response and a decrease in polymorphonuclear cell migration and activation after 17boestradiol treatment. Moreover, inducible NO synthetase activity was decreased, as well as the subsequent formation of free radical species. Again, as in OVX rats, inflammation was not associated with a significant oxidative stress development, even though there was a trend to Mean values were significantly different from those of the OVX inf: *P, 0·05. Mean value was significantly different from those of the OVX: ***P, 0·001. † For details of diets and procedures, see Table 2 and pp. 120-121.
higher malondialdehyde levels (after lipid peroxidation induction). However, inflammation induced a significant body-weight loss due to anorexia, because rats bearing talc granulomas eat less than intact animals (Vukicevic et al. 1994) .
In conclusion, in the rat, inflammation exacerbated osteopenia induced by ovariectomy, making this model suitable for the study of senile osteoporosis. The present study demonstrates that oleuropein and extra virgin olive oil were able to elicit protective effects on bone loss in this model of ovariectomy associated with inflammation, probably by modulating variables of inflammation (such as a-1-acid glycoprotein). However, they did not have any effect on BMD when inflammation was not performed. These present results strengthen the current hypothesis that micronutrients could be of importance in degenerative conditions involving changes in the inflammatory status.
